LONDON (Alliance News) - Venn Life Sciences PLC, a clinical research organisation, said Thursday it has shown continued growth so far in 2015 and increased company billings significantly.
Venn Life said it had a strong first half of 2015, with company billings greater than EUR4.0 million, more than double the EUR1.5 million it billed in the same period last year. The group said contract wins totalled more than EUR9.0 million in the half to the end of June.
"Our fee income figures highlight the steady and consistent growth of Venn Life year on year with both repeat business and organic growth contributing to our excellent results and ability to win projects internationally. Our market continues to grow steadily and with a healthy pipeline of prospects we are well positioned to deliver further growth," Venn Life Chief Executive Officer Tony Richardson said.
Venn Life will announce its interim results for the six months ended June 30 on the September 22 .
By Preten Patel; pretenpatel@alliancenews.com
Copyright 2015 Alliance News Limited. All Rights Reserved.
